Finally, the MC3/4R antagonist SHU-9119 was able to significantly decrease BP in pharmacological-induced hypertension upon chronic infusion of nitric oxide synthase inhibitor (L-NAME) (Da Silva et al., 2015). Here, MC3R is linked to hypertensive disorder.